The role of hyaluronic acid as a mediator and regulator of cervical ripening.
During pregnancy, hyaluronic acid (HA) concentration in the human cervix is very low, but increases rapidly at the onset of labour. HA has a high affinity for water molecules and hence can maintain tissue hydration. HA can stimulate collagenase production in rabbit cervix, and also stimulates migration and function of polymorphonuclear leukocytes in the tissues. It is an endogenous regulator of interleukin-1 (IL-1). We hypothesized that HA plays an essential role during cervical ripening. The effect of exogenous application of HA (20 mg) on non-pregnant and pregnant (day 23) rabbit cervices was compared with controls. HA induced cervical ripening in both pregnant and non-pregnant animals, and cervical water content was significantly increased. Tissue collagen was markedly decreased. The localization and distribution of HA and HA receptor CD44 was determined in non-pregnant and pregnant human cervical connective tissue using biotinylated HA binding protein and CD44 monoclonal antibodies. Both were widely distributed in the connective tissues, especially around the blood vessels and cervical glands. The effect of IL-8 (50, 100, 150 and 200 ng/ml) on HA production and hyaluronidase (HAase) activity was investigated in cultures of lower uterine segment collected during elective Caesarean sections. HA production was stimulated in a dose-dependent manner; there was no effect on hyaluronidase activity. HA administration (0.5, 1 and 2 mg/ml) stimulated the activities of collagenase and gelatinase together with IL-8 production in the culture supernatants. Thus HA may play an important role in cervical ripening, being involved in the regulation of cervical tissue water content, collagenolytic enzymes and cytokines.
El Maradny
E
E
Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Handa-cho, Japan.
Kanayama
N
N
Kobayashi
H
H
Hossain
B
B
Khatun
S
S
Liping
S
S
Kobayashi
T
T
Terao
T
T
D000282:Administration, Intravaginal; D000818:Animals; D002584:Cervix Uteri / Q000737:chemistry / Q000187:drug effects / Q000502:physiology*; D003094:Collagen / Q000032:analysis / Q000187:drug effects / Q000648:ultrastructure; D017364:Collagenases / Q000187:drug effects / Q000378:metabolism; D046508:Culture Techniques; D004305:Dose-Response Relationship, Drug; D005260:Female; D018093:Gelatinases / Q000187:drug effects / Q000378:metabolism; D006651:Histocytochemistry; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D006821:Hyaluronoglucosaminidase / Q000378:metabolism; D007150:Immunohistochemistry; D016209:Interleukin-8 / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D009215:Myometrium / Q000737:chemistry* / Q000187:drug effects / Q000201:enzymology; D011247:Pregnancy; D011817:Rabbits; D013488:Suppositories; D014867:Water / Q000032:analysis
D018960:Hyaluronan Receptors; D016209:Interleukin-8; D013488:Suppositories; D014867:Water; D006820:Hyaluronic Acid; D003094:Collagen; D006821:Hyaluronoglucosaminidase; D017364:Collagenases; D018093:Gelatinases